3′‐(4‐(Benzyloxy)phenyl)‐1′‐phenyl‐5‐(heteroaryl/aryl)‐3,4‐dihydro‐1′ H ,2 H ‐[3,4′‐bipyrazole]‐2‐carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies-Reference-Cited by-同舟云学术

3′‐(4‐(Benzyloxy)phenyl)‐1′‐phenyl‐5‐(heteroaryl/aryl)‐3,4‐dihydro‐1′ H ,2 H ‐[3,4′‐bipyrazole]‐2‐carboxamides as EGFR kinase inhibitors: Synthesis, anticancer evaluation, and molecular docking studies

Published:2020-04 Issue:4 Volume:353 Page:1900262
ISSN:0365-6233
Container-title:Archiv der Pharmazie
language:en
Short-container-title:Arch. Pharm.

Author:

Nawaz Farah¹,Alam Ozair¹^ORCID,Perwez Ahmad²,Rizvi Moshahid A.²,Naim Mohd. J.¹,Siddiqui Nadeem¹,Pottoo Faheem H.³,Jha Mukund¹

Affiliation:

1. Medicinal Chemistry and Molecular Modelling Lab, Department of Pharmaceutical Chemistry, School of Pharmaceutical Education and ResearchJamia HamdardNew Delhi India

2. Genome Biology Lab, Department of BiosciencesJamia Millia IslamiaNew Delhi India

3. Department of Pharmacology, College of Clinical PharmacyImam Abdulrahman Bin Faisal UniversityDammam Saudi Arabia

Funder

Department of Science and Technology, New Delhi, India

Publisher

Wiley

Subject

Drug Discovery,Pharmaceutical Science

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ardp.201900262

Reference44 articles.

1. Synthesis and pharmacological evaluation of some new fluorine containing hydroxypyrazolines as potential anticancer and antioxidant agents